Cost and utilization outcomes of pharmacist-led medication therapy optimization in a Medicare ACO population
Hazem F Elewa, Joseph F Levy, Chintan Pandya, Steven E Goldberg, Travis A Morgan · 2026
Read Cost and utilization outcomes of pharmacist-led medication therapy optimization in a Medicare ACO population by Hazem F Elewa, Joseph F Levy, Chintan Pandya, Steven E Goldberg, Travis A Morgan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13602420.txt.
Description
Hazem Elewa and four co-authors evaluate a pharmacist-led program that fine-tunes medications for Medicare patients in an accountable care group. Drug problems drive much avoidable spending on seniors. The program mixed genetic testing, a nine-factor risk score, full pharmacist review, and written advice to prescribers. Using matched comparisons on claims from 2022 to 2025, the study tracked 1,003 treated members against 14,031 similar controls.
Total medical costs fell 19.4 percent for treated members, about two hundred forty-six dollars per member per month. The saving deepened with time in the program, reaching 31.9 percent after nine months. Hospital admissions dropped forty-three percent, emergency visits forty-one percent, and outpatient visits twenty-eight percent. Checks on pre-trends and the steady dose-response support a real effect. The authors warn that short studies will badly underrate such programs.
Catalog record
| CREATOR | Hazem F Elewa, Joseph F Levy, Chintan Pandya, Steven E Goldberg, Travis A Morgan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |